We definitely missed the boat at some level, with an approved treatment out that improves outcomes like this.

But maybe not entirely. Maybe still relevant if rvx could ever get their trial going... esp re long covid etc.

Oh wait they didn't even design in a look at long covid into this never endingly awaited trial.  :/

https://www.webmd.com/vaccines/covid-19-vaccine/news/20210826/monoclonal-antibodies-vs-vaccines-vs-covid-19